Sat.Mar 20, 2021 - Fri.Mar 26, 2021

article thumbnail

U.S. Health Officials Question AstraZeneca Vaccine Trial Results

NY Times

According to federal officials, an independent panel of medical experts said the promising results announced by the company on Monday may have relied on “outdated information.”.

Vaccines 140
article thumbnail

Gamification for patient care, medical education, and virtual engagement

pharmaphorum

“Gamification” – adding game-like elements into non-game or real-world settings – has become a popular concept in the pharmaceutical, healthcare, and event industries, especially as virtual engagement becomes more common during COVID-19. However, it is proving more than a mere buzzword. With diverse applications and approaches, it is quickly becoming a promising tool for patient adherence, chronic disease management, preventive medicine, rehabilitation, and paediatric care, as well as for medica

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Life-sciences pros believe in potential of AI, blockchain: survey

Outsourcing Pharma

A survey by the Pistoia Alliance indicates most professionals believe the tech can accelerate R&D, but companies are stymied by a skills gap and data bias.

145
145
article thumbnail

“Can You Hear Me?” – The (Hopefully) Coming Transition from Virtual Meetings

Eye on FDA

Today, FDA published notice in the Federal Register of an upcoming meeting of the Arthritis Drugs Advisory Committee that will be held May 6. The meeting will be held virtually. Last year when the pandemic reality started setting in, like everyone else FDA had to change operations – in some cases shutting down or curtailing activities altogether and moving others to a virtual stage.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

AstraZeneca’s Covid-19 Vaccine Is Found to Be 79% Effective in U.S. Study

NY Times

The company is preparing to apply for emergency authorization from the Food and Drug Administration. But the shot may not be needed in the United States.

Vaccines 112
article thumbnail

Health tech and digital transformation lessons from the NHS

pharmaphorum

In the year since the UK went into its first lockdown to limit the spread of COVID-19 the country’s health service has undergone an unprecedented digital transformation. . The NHS quickly scrambled to reduce face-to-face contact between patients and healthcare professionals, and manage demand for services that would soon be overstretched by dealing with the pandemic.

Vaccines 141

More Trending

article thumbnail

MedVector introduces patient enrollment expansion solution

Outsourcing Pharma

The companyâs Prime-Control Technology is designed to help study teams expand their subject enrollment beyond the reach of their clinical trial sites.

98
article thumbnail

Some Nations Could Wait Years for Covid Shots. That’s Bad for Everyone.

NY Times

While richer places, such as the U.S., hope to vaccinate most of their citizens within months, poorer countries, like Kenya, expect to reach just small fractions of their populations in that time.

article thumbnail

Novartis’ radioligand therapy meets phase 3 prostate cancer trial target

pharmaphorum

Novartis’ radioligand therapy Lu-PSMA-617 has met its target in prostate cancer, as its $2.1 billion acquisition of specialist pharma Endocyte looks to have been justified. . The big Swiss pharma added this drug to its pipeline after it swooped for Endocyte and so far it looks like a good piece of business, with potential blockbuster sales predicted for the drug if it makes it to market.

article thumbnail

FDA nod for Kiniksa’s Arcalyst in recurrent pericarditis

Pharma Times

Recurrent pericarditis is an autoinflammatory cardiovascular disease

130
130
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Cancer research benefits from harnessing real-world data

Outsourcing Pharma

A leader from oncologist-founded trial tech specialists COTA shares how advanced data analysis can benefit cancer researchers and patients alike.

98
article thumbnail

AstraZeneca’s Covid-19 Vaccine Found to Be 79% Effective in U.S. Study

NY Times

The vaccine maker is preparing to apply for emergency authorization from the Food and Drug Administration. But the vaccine may not be needed in the United States.

article thumbnail

COVID-19 underscores need to boost pharma manufacturing in emerging markets

pharmaphorum

For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. The scramble to produce vaccines and therapeutics and the challenges of getting these products to poorer countries underscores the growing importance of local pharma manufacturers for these emerging markets. .

Vaccines 122
article thumbnail

Relugolix shows potential long-term benefit in women with uterine fibroids

Pharma Times

Study compared women who continued on relugolix combination therapy with women who discontinued treatment

105
105
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Bulgaria?

Drug Patent Watch

This chart shows the drugs with the most patents in Bulgaria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Bulgaria? appeared first on DrugPatentWatch - Make Better Decisions.

87
article thumbnail

Cache of 29 Million AstraZeneca Doses in Italy Raises E.U. Suspicions

NY Times

The company has been at loggerheads with the bloc over vaccine supply shortages and faces stringent export restrictions.

Vaccines 111
article thumbnail

Pfizer begins clinical trials of COVID-19 antiviral pill

pharmaphorum

Pfizer has begun clinical development of an antiviral pill against COVID-19, which could be prescribed to patients at the first sign of infection. The company was the first to get a vaccine approved against the disease with BioNTech and is now aiming to make a pill that could prevent it escalating once patients are infected. Being able to manage coronavirus infections and prevent hospitalisations and death would have huge benefits for wider society as well as patients after more than a year of l

Vaccines 119
article thumbnail

Cambridge start-up PhoreMost raises £33m to progress PLK1 programme

Pharma Times

Lead ‘Allosteric PLK1’ asset will initially target brain cancer

119
119
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Which drugs have supplementary protection certificates in the most countries?

Drug Patent Watch

This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…. The post Which drugs have supplementary protection certificates in the most countries? appeared first on DrugPatentWatch - Make Better Decisions.

81
article thumbnail

Digital Tools at the Center of Healthcare Digitalization

Pharma Marketing Network

Innovation During COVID-19 Fact Sheet. We compiled a fact sheet on innovations in digital publishing that sparked due to the pandemic and have since been soaring. . Get your complimentary copy of "The Publishing Industry: The Soar of Innovation During COVID-19 Fact Sheet". Name *. First. Last. Company Email *. Lead Source * Web Active Prospecting Sales Ad-Label Advertising - Offline Advertising - Online Advertising - Online - FocalPoint Advertising - Online - Mobile Advertising - Online - Trend

article thumbnail

Cancer services should be rebuilt after COVID disruption, experts say

pharmaphorum

There is a pressing need for a joined-up cancer strategy to reverse the impact of the COVID-19 pandemic, according to a new report from the UK’s pharma industry. The Association of the British Pharmaceutical Industry ( ABPI) report said that the UK must be more ambitious with its cancer strategy if it is to compete with the leading nations across Europe.

111
111
article thumbnail

EMA accepts Astellas/Seagen’s enfortumab vedotin for review

Pharma Times

Marketing authorisation application is seeking approval for advanced urothelial cancer

109
109
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Which pharmaceutical companies have the most SPCs in France?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in France. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in France? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Online health communities connect patients, trial teams

Outsourcing Pharma

Health Union offers patients dealing with a range of conditions ways to connect with valuable information, research opportunities and each other online.

72
article thumbnail

Boris Johnson slammed for saying “greed” is behind UK vaccine success

pharmaphorum

Boris Johnson’s sense of humour seems to have got him into trouble again, at the most delicate of times. The Prime Minister reportedly told Conservative backbench MPs on a Zoom call that “capitalism” and “greed” was behind the success of the UK’s COVID-19 vaccination programme, before backtracking after realising he had made a blunder and telling attendees to forget the comments.

Vaccines 121
article thumbnail

Roche’s Tecentriq improves disease-free survival in early lung cancer

Pharma Times

Tecentriq is approved in five lung cancer indications currently

122
122
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Supply Isn’t the Only Thing Stymying Europe’s Vaccine Rollout

NY Times

Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.

article thumbnail

IQVIA expands reach of its decentralized trial solutions

Outsourcing Pharma

The company reports that its patient-centric virtual study technology currently is in use in more than 60 ongoing trials in over 40 different countries.

72
article thumbnail

Shock as AstraZeneca’s charismatic cancer R&D chief José Baselga dies

pharmaphorum

AstraZeneca is mourning the loss of one of its top scientists after eminent cancer researcher José Baselga passed away at the age of just 61. . Baselga was a heavyweight in oncology research, pursuing a career that saw him serve as physician-in-chief at Memorial Sloan Kettering Cancer Centre in the US and also hold the position as president of the American Association of Cancer Research (AACR) before joining AZ to lead the drugmaker’s cancer R&D in January 2019.

article thumbnail

‘Formal review’ of GP access arrangements needed, says Healthwatch

Pharma Times

UK-based charity conducted a review of GP access between April 2019 and December 2020

107
107
article thumbnail

José Baselga, Who Advanced Breast Cancer Treatments, Dies at 61

NY Times

He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at AstraZeneca.

65